Meet ASPIRE: Galderma Rolls Out New Customer Loyalty Program
Galderma is rolling out a new loyalty program for both doctors and patients.
Tag: Galderma
All
PopularAll
Latest
Integrating Financing and Rewards to Build Patient Loyalty
Two physicians discuss how integrated patient financing and loyalty programs are transforming access, affordability, and retention in aesthetic practices.
All
Latest
Cutera Announces New Global Initiative Celebrating Laser Aesthetics
Cutera has launched Global Laser Aesthetics Month this October to spotlight laser technology, skin diversity, and provider and patient education.
Galderma Sponsors SCOPE Miami Beach 2022
Galderma is sponsoring the SCOPE Miami Beach 2022 showcase for contemporary art, offering consultations and real-time treatments to visitors.
Read More
Galderma, NBCF to Launch Campaign Elevating Skin Stories of Breast Cancer Survivors
Galderma is featuring the personal stories and treatment journeys of breast cancer survivors who received Galderma’s aesthetic portfolio of products in a campaign on their social channels during Breast Cancer Awareness Month in October.
Read More
Galderma Phase 3 Trial Shows Wrinkle Reducing Results
Galderma’s wrinkle treatment, RelabotulinumtoxinA, reduced wrinkles with minimal side effects in two phase III clinical studies.
Read More
Galderma to Present New Clinical Data On Portfolio of Products
Galderma will share a host of clinical and patient satisfaction data on its portfolio of products at the AMWC in Monaco.
Read More
Galderma Launches Alastin Skincare ReFORM & RePAIR COMPLEX with TriHex Technology
The newest product in the Alastin Skincare line, it’s designed to assist with recovery from aesthetic surgical body procedures.
Read More
Galderma Successfully Completes Acquisition of ALASTIN Skincare
Galderma announces that it has received antitrust clearance from the US authorities and has completed the acquisition of ALASTIN Skincare Inc.
Read More
Galderma Receives FDA Approval for New SCULPTRA Label, Offering More Options to Aesthetic Partners
Galderma announces the new label for SCULPTRA (injectable poly-L-lactic acid (PLLA)), the first and only FDA-approved PLLA facial injectable treatment that helps stimulate the skin’s own collagen production, to smooth facial wrinkles, such as smile lines.
Read More
Aesthetics Biomedical Inc Announces Perspectives Symposium
On the heels of Aesthetics Biomedical’s inaugural symposium launched in Phoenix (April 2021) comes the follow-up activation, Perspectives: The Evolution of Aesthetics, a boutique-style symposium is taking place in Orlando, Fla.
Read More
New MENTOR, Galderma Partnership Rewards Breast Implant Patients, and Practitioners
Doctors gain access to key insights about the products, utilizing business-building tools that encourage each patient’s aesthetic journey.
Read More
FDA Approves Restylane Contour
Galderma’s first and only product in the U.S. to use proprietary XpresHAn Technology for the cheeks is coming to practices this summer.
Read More
Galderma Launches Multichannel Medical Education Platform
Galderma announces the launch of its Galderma Excellence in Multichannel Medical Education (GEMME) platform with a four-part webinar series: “Unmasking Facial Skin & Dermatoses.”
Read More
COVID-19 Mask Wearing Could Be Worsening Rosacea
A recent survey conducted by Galderma suggests that the pandemic may impact rosacea patients, from worsening of signs and symptoms related to mask wearing, to reduced HCP consultations.
Read More
Latest FDA Approval Helps Galderma Expand a Growing Restylane Product Portfolio
According to reports, in 2020, online searches for chin enhancement products, like Restylane Defyne, increased by 185%.
Read More
New Galderma Face for Change Program Runs Through February
Partnerships with Dress for Success and the Skin Cancer Foundation provide an opportunity to give back, with each Dysport for injection treatment.
Read More
Galderma Releases Top-line Results from Phase 2 Clinical Dose-Escalating Study with Dysport (Azzalure)
Based on encouraging safety and long-term efficacy results of the Dysport study, and continued patient satisfaction, the company is evaluating future clinical studies.
Read More